Loading compare…
6 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 6 mutual funds hold active equity positions in both Indoco Remedies and Sun Pharmaceutical Industries. The scheme with the highest combined exposure is Nippon India Pharma Fund (Nippon India MF), which holds a 0.84% stake in Indoco Remedies and a 13.81% stake in Sun Pharmaceutical Industries, amounting to a combined conviction weight of 14.65%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Indoco wt. | Sun wt. | Combined |
|---|---|---|---|
| Nippon India Pharma FundNippon India MF · Sectoral / Thematic | 0.84% | 13.81% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.05% | 13.32% | |
| ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Pru MF · Sectoral / Thematic | 0.54% | 12.69% | |
| DSP Healthcare FundDSP MF · Sectoral / Thematic | 1.96% | 8.42% | |
| HDFC Value FundHDFC MF · Value | 0.42% | 2.26% | |
| Nippon India Small Cap FundNippon India MF · Small Cap | 0.18% | 0.31% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.